Skip to content

Author

Andrea Koly

We have 1 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access

The Neuroprotective Effect of Cdc42 Inhibition in the G93A Mutant hSOD1 Mouse Model of ALS

It is suggested that Cdc42 inhibition can preserve neuromuscular structure and motor function in ALS, even in the absence of prolonged survival, and Cdc42 is identified as a novel contributor to ALS pathogenesis and a promising therapeutic target for slowing functional decline.

Andrea Koly · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.